Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

C-cell hyperplasia.

Guyétant S, Bléchet C, Saint-André JP.

Ann Endocrinol (Paris). 2006 Jun;67(3):190-7. Review.

PMID:
16840909
2.
3.

C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.

Guyétant S, Josselin N, Savagner F, Rohmer V, Michalak S, Saint-André JP.

Mod Pathol. 2003 Aug;16(8):756-63.

4.

Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.

Hinze R, Holzhausen HJ, Gimm O, Dralle H, Rath FW.

Virchows Arch. 1998 Sep;433(3):203-8.

PMID:
9769122
5.

Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene.

Foppiani L, Forzano F, Ceccherini I, Bruno W, Ghiorzo P, Caroli F, Quilici P, Bandelloni R, Arlandini A, Sartini G, Cabria M, Del Monte P.

Eur J Endocrinol. 2008 Mar;158(3):417-22. doi: 10.1530/EJE-07-0608.

6.

[Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].

Ting S, Synoracki S, Schmid KW.

Pathologe. 2015 May;36(3):246-53. doi: 10.1007/s00292-015-0019-x. Review. German. Erratum in: Pathologe. 2015 Nov;36(6):571.

PMID:
25898937
7.

[Non-neoplastic hypercalcitoninemia. Pathological anatomy].

Saint-André JP, Guyétant S.

Ann Endocrinol (Paris). 1996;57(1):23-6. Review. French.

PMID:
8734285
8.

["Physiological" and "neoplastic" C-cell hyperplasia of the thyroid. Morphologically and biologically distinct entities?].

Hinze R, Gimm O, Brauckhoff M, Schneyer U, Dralle H, Holzhausen HJ.

Pathologe. 2001 Jul;22(4):259-65. German.

PMID:
11490939
9.

C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.

Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Haas OA, Niederle B.

Am J Surg Pathol. 1998 Jun;22(6):722-8.

PMID:
9630179
10.

Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?

Verga U, Ferrero S, Vicentini L, Brambilla T, Cirello V, Muzza M, Beck-Peccoz P, Fugazzola L.

Endocr Relat Cancer. 2007 Jun;14(2):393-403.

11.
12.

Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia.

Saggiorato E, Rapa I, Garino F, Bussolati G, Orlandi F, Papotti M, Volante M.

J Mol Diagn. 2007 Apr;9(2):214-9.

13.

The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.

Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA, Niederle B.

Thyroid. 2008 Dec;18(12):1269-76. doi: 10.1089/thy.2008.0139.

PMID:
18976163
14.

Multiple endocrine neoplasia type 2A. Study of a family.

Correia MJ, Lopes LO, Bugalho MJ, Cristina L, Santos AI, Bordalo AD, Pinho B, da Silva HL, Gonçalves MD, Ribeiro C, Tuna JL.

Rev Port Cardiol. 2000 Jan;19(1):11-31. Review. English, Portuguese.

PMID:
10731788
15.

Incidental thyroid C cell hyperplasia: clinical significance and implications in practice.

Sakorafas GH, Nasikas D, Thanos D, Gantzoulas S.

Oncol Res Treat. 2015;38(5):249-52. doi: 10.1159/000381605. Epub 2015 Apr 17. Review.

PMID:
25966772
16.

[Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].

Synoracki S, Schmid ST, Ting S, Schmid KW.

Pathologe. 2015 May;36(3):254-60. doi: 10.1007/s00292-015-0017-z. Review. German.

PMID:
25917773
17.

Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.

Ercolino T, Lai R, Giachè V, Melchionda S, Carella M, Delitala A, Mannelli M, Fanciulli G.

Gene. 2014 Feb 25;536(2):332-5. doi: 10.1016/j.gene.2013.12.003. Epub 2013 Dec 21.

PMID:
24361808
18.

When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?

Calva D, O'Dorisio TM, Sue O'Dorisio M, Lal G, Sugg S, Weigel RJ, Howe JR.

Ann Surg Oncol. 2009 Aug;16(8):2237-44. doi: 10.1245/s10434-009-0524-3. Epub 2009 May 27.

PMID:
19472011
19.

Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.

Michiels FM, Chappuis S, Caillou B, Pasini A, Talbot M, Monier R, Lenoir GM, Feunteun J, Billaud M.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3330-5.

Supplemental Content

Support Center